Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Open access

 

Interview: Sam Myers, Principal, Balderton Capital

Early-stage investor Balderton can namedrop the likes of Betfair, Lovefilm and Citymapper among its past and present portfolio. Based in London, and with a $2.3bn fund, it has a track record of building successful consumer businesses across Europe, but has also taken a liking to healthcare with investments in MyTomorrows, PatientsKnowBest and Circle Health. Myers, who heads-up the firm’s Nordic portfolio, thinks it’s only a matter of time before the European consumer has the health system at its finger tips. Here he gives his thoughts on when.

Healthcare Europa June 2017

In this month's Europa, we cover deals for Domus Vi and GCC Genetics, elections in France and the UK and bring you interviews with Medical Properties Trust, Wellmo, Health[at]Scale and Ottonova.

Interview: William Stoddart, CEO, Werlabs

Werlabs is a Swedish start-up bringing lab tests to the general public. The group is growing fast from a small base, and is now expanding beyond the Nordics. Its CEO, William Stoddart, believes it can save the health system money and consumers will buy it. Healthcare Europa asks him how.

B2C lab tests set to soar in Europe

Direct-to-consumer lab groups are popping up right across Europe. Most are small and offer a limited range of tests, but there’s less to stop labs going straight to the consumer than you might have thought.

Who will fund WHO’s push for UHC in Africa?

Donor fatigue and finance ministries that are reluctant to pay for healthcare means private capital could be vital in achieving universal health coverage, said experts at the launch of the Economist Intelligence Unit’s (EIU) report on global access to healthcare last week.

Find Us